Personalis IncEigentümerstruktur
| Preis (2026-07-24) | 52W Hoch | 52W Tief |
| 11.78 USD | 16,39 USD | 3,84 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 13,875 USD | 4 | 2 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 106.750.881 | 16,74 | 2,51 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Personalis Inc
Mitarbeiter 259
Handelsplatz NASDAQ
Ticker Symbol PSNL
IPO Datum 2019-06-20
Adresse 6600 Dumbarton Circle, Fremont, CA, United States, 94555
Webseite https://www.personalis.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Christopher M. Hall | CEO & Director |
| 2 | Mr. Aaron L. Tachibana | CFO & COO |
| 3 | Dr. Russ B. Altman M.D., Ph.D. | Co-Founder and Member of Clinical & Scientific Advisory Board |
| 4 | Dr. Euan Angus Ashley DPHIL, FRCP, M.D., Ph.D. | Co-Founder and Member of Clinical & Scientific Advisory Board |
| 5 | Dr. Michael P. Snyder Ph.D. | Co-Founder and Member of Clinical & Scientific Advisory Board |
| 6 | Mr. Ashish Kheterpal | Senior VP & Chief Information Officer |
| 7 | Mr. Stephen M. Moore J.D. | Senior VP, Chief Legal Officer & Corporate Secretary |
| 8 | Dr. Christian Haudenschild Ph.D. | Senior Vice President of Genomic Science |
| 9 | Mr. Stephane Mouradian Ph.D. | Senior Vice President of Business Development |
| 10 | Ms. Deepshikha Bhandari | Senior Vice President of Regulatory, Quality & Clinical Compliance |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Merck & Co Inc | 0,00% | 0,00 Mio. USD |
| 2 | Lightspeed Management Co LLC | 0,00% | 0,00 Mio. USD |
| 3 | ARK Investment Management LLC | 0,00% | 0,00 Mio. USD |
| 4 | Ameriprise Financial Inc | 0,00% | 0,00 Mio. USD |
| 5 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 6 | T. Rowe Price Investment Management,Inc. | 0,00% | 0,00 Mio. USD |
| 7 | Aberdeen Group PLC | 0,00% | 0,00 Mio. USD |
| 8 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 9 | Deep Track Capital, LP | 0,00% | 0,00 Mio. USD |
| 10 | AIGH Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 11 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 12 | Kennedy Capital Management Inc | 0,00% | 0,00 Mio. USD |
| 13 | Blue Water Life Science Advisors, LLC | 0,00% | 0,00 Mio. USD |
| 14 | T. Rowe Price Associates, Inc. | 0,00% | 0,00 Mio. USD |
| 15 | Casdin Capital, LLC | 0,00% | 0,00 Mio. USD |
| 16 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 17 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 18 | Dimensional Fund Advisors, Inc. | 0,00% | 0,00 Mio. USD |
| 19 | Partner Fund Management LP | 0,00% | 0,00 Mio. USD |
| 20 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |